Montelukast Sodium

Category API

Details	Specifications
CAS Number	151767-02-1
Molecular Formula	C35H35NNaO3ClS
Molecular Weight	608.18 g/mol.
Synonyms	[Sodium (R, E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl) vinyl) phenyl)-3-(2-(2-hydroxypropan-2-yl) phenyl) propyl) thio) methyl) cyclopropyl) acetate](https://www.ncbi.nlm.nih.gov/pcsubstance/?term=%22sodium%20(R%2CE)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetate%22%5bCompleteSynonym%5d%20AND%2023663996%5bStandardizedCID%5d)
Chemical Name	[R-(E)]-1-[1-[3-[2-(7-chloro-2-quinolinyl) ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl) propyl] thio] methyl] cyclo propane acetic acid, monosodium salt
Common name	Montelukast Sodium
Therapeutic use	Leukotriene receptor antagonists (LTRAs)
Background	Montelukast sodium, the active ingredient in SINGULAIR*, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. It is also broadly classified as an antiasthma tic and antiallergic agent
Grade	EP & USP
Polymorph	Amorphous
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	CEP 2024-125
Manufacturing batch size	51.0 Kg
Production capacity	Annual capacity is 3 – 4 tonnes
Stability data	Available

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Montelukast Sodium are also Available for

Questions & Answers

FAQ on Montelukast Sodium

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.